GlassScriptPhysician profile
Ryan Gordon Holstead
NPI 1952753873
$1,164.27
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $376 · 2023: $144 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $187.60 | 2021-2023 | Opdivo, Opdualag |
| Celgene Corporation | $172.82 | 2021-2022 | |
| Galvanize Therapeutics, INC | $167.10 | 2024 | Aliya System |
| Amgen INC. | $164.31 | 2021-2023 | Nplate, Vectibix, Xgeva |
| Novartis Pharmaceuticals Corporation | $82.24 | 2021-2023 | |
| Pfizer INC. | $36.54 | 2022 | |
| Janssen Biotech, INC. | $30.78 | 2022 | |
| Seagen INC. | $29.53 | 2021-2022 | |
| Puma Biotechnology, INC. | $26.20 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $25.00 | 2021 | |
| Blue Earth Diagnostics | $24.82 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $24.21 | 2022 | |
| Incyte Corporation | $22.31 | 2022 | |
| Global Blood Therapeutics, INC. | $21.16 | 2021 | |
| Sun Pharmaceutical Industries INC. | $20.62 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $19.59 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.50 | 2022 | |
| Genzyme Corporation | $16.49 | 2021 | |
| Glaxosmithkline, LLC. | $16.41 | 2022 | |
| Genentech USA, INC. | $16.39 | 2021 | |
| Exelixis INC. | $15.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Holstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.